AstraZeneca Pharma India receives approval for supplying Osimertinib in India

The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases

Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI

BMS is moving beyond conversational AI into what it describes as “agentic” systems

Decoding teleophthalmology role in transforming last-mile eye care in India

By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease

OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets

The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego

Dyno unveils next-gen AI-designed gene delivery capsids targeting brain & muscle

This positions its platform as a rapidly evolving engine for next-generation genetic medicine

Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer

Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare

Access to genomic testing, not therapy cost, is the biggest challenge